The binding of A13+ by human serum transferrin has been investigated by u.v.-visible difference spectroscopy. In the presence of 25 mM-HC03-at pH 7.4, the apparent association constants were found to be 1.69 x 1012 M-1 and 5.36 x 1011 M-1. These association constants are pH-dependent, reducing with both increasing and decreasing pH. 
MATERIALS AND METHODS
Recent reports suggest that A13+ may be involved in the biochemistry of various animal diseases [see Kerr & Ward (1988) , Perl (1988) and references therein]. Underpinning these reports are the undoubted facts that A13+ can be taken up by animals and localized at various points within their bodies where biochemical lesions occur. In the present paper we address the question: how is A13+ transported in blood serum?
A13+ is not very soluble in water over the pH range 5-9 unless it is bound to a water-soluble ligand (Ganrot, 1986 ). Blood plasma contains many small molecules that are potential ligands (May et al., 1977; Bell et al., 1988; Harris & Sheldon, 1990) , as well as the metal-binding proteins transferrin and albumin (Aisen & Listowsky, 1980; Brock, 1985; Peters, 1985) . Thus a relatively large amount of A13+ can be solubilized in blood plasma.
The uptake of A13+ from the blood by tissues depends upon the properties of the Al3+-ligand complexes. Thus the distribution of A13+ between different ligands is valuable information. A variety of techniques have been applied to investigate the speciation of A13+ in serum, including calculations based on known stability constants (Martin, 1980; Harris & Sheldon, 1990 ) and fractionation of serum by column chromatography (King et al., 1979 (King et al., , 1982 Bertholf et al., 1984; Farrar et al., 1990) . These studies have given conflicting results. For example, it has been suggested that the main carrier of A13+ in normal human blood is human serum transferrin (HSTF) (Trapp, 1983; Rahman et al., 1986) , a combination of transferrin and human serum albumin (HSA) (Bertholf et al., 1984) , or a combination of HSTF and citrate, with HSTF being the carrier of -80 % of the A13+ (Martin, 1980 (Martin, , 1988 Martin et al., 1987; Wills & Savory, 1988 The second series of experiments required 2.5 ml aliquots of HSTF (7.6 ,UM) in 0.1 M-Tris (containing 40 mM-NaCl and 25 mmNaHCO3 at pH 7.4). These were placed in a number of sample and reference cuvettes. To each of these an appropriate amount of sodium citrate, or HSA, or both (in 0.1 M-Tris containing 40 mM-NaCl at pH 7.4) was added to give a concentration of 22 tM-citrate or 13 uM-albumin. Aliquots (5-10,ul) of 1 mmAlK(SO4)2,12H20 were then added to the sample cuvettes, and an equal volume of distilled water was added to the reference cuvette, and the difference procedure above was carried out.
The effect of pH on the Al-HSTF association was investigated in two ways. Firstly, the relationship between A240 and pH was investigated for a solution of transferrin fully saturated with Al3+. Apotransferrin solution, at the same concentration but with no Al3+ added, was introduced into a reference cell as a blank. The pH of the solution in the sample cuvette was adjusted by adding HCI or NaOH, and after 1 h, to allow complete equilibration of the Al-HSTF complex to occur, spectra were taken from 340 to 200 nm.
Secondly, a series of samples was prepared by dissolving 6 mg of purified HSTF in 6 ml of 0.1 M-buffer at three different pH values: 6.5, 7.4, and 8.5. The procedure for monitoring the binding of Al3+ to HSTF described above was then carried out for each solution.
In studying the competitive binding of Fe3+ and Al3+ to HSTF, the following procedures were employed.
Firstly, a solution of HSTF (14 ,uM), in 0.1 M-Tris (containing 40 mM-NaCl and 25 mM-NaHCO3 at pH 7.4), was equilibrated with 2 equiv. of Al3+ for 1-2 h. Equal volumes of this solution were added to both the sample and a reference cell, and a baseline of Al-HSTF against Al-HSTF was recorded. Fe3s olution was then added, in 5-10,ul aliquots, to the sample cuvette, and equal volumes of distilled water were added to the reference cell. Spectra were taken 1 h after each addition. Titration was continued up to a Fe3+/HSTF ratio of 2:1.
Secondly, a similar titration was carried out for Fe-HSTF (2: 1 molar ratio) using Al3+ solution as a titrant.
Thirdly, 3 ml of apotransferrin solution was added to both a sample and a reference cell, and Fe3+ solution was added to the sample cell up to 2 equiv. of Fe3+/HSTF solution. The resulting solution was titrated with 5-10 4u1 aliquots of Al3+ solution up to an Al/Fe ratio of 50: 1.
RESULTS AND DISCUSSION
Binding of Al3+ to HSTF Addition of Al3+ to HSTF (in 0.1 M-Tris/40 mM-NaCl at pH 7.4 and at 25°C) in the presence of HCO3-was accompanied by an increased absorbance in the difference spectrum at 240 and 290 nm. This is broadly in agreement with the observations of Cochran et al. (1984, 1987) , Trapp (1983) and Tomimatsu & Donovan (1977) . A typical series of spectra from 350 to 190 nm is shown in Fig. 1 . A titration curve of the ratio of the measured absorbance maximum at 240 nm divided by the total HSTF concentration, to give a value for As, against the ratio of the total Al3+ concentration to the total HSTF concentration, is given in Fig. 2 (Williams et al., 1978; Brock, 1985) , and the differences between K: values and between K: values for the same metal ions binding to transferrin and lactoferrin (Brock, 1985) , may Bailey et al., 1988) . This situation resembles the variation in redox potential for haemoproteins with common haem-binding sites; for example, class I cytochromes c. In such cases the redoxpotential variation is largely due to electrostatic effects modulating the stabilities of the Fe3+ ions [see Moore & Pettigrew (1990) Fig. 3 . The A240 of the solution decreased from the value obtained at pH 7.4 as the pH changed. The pH profile of absorbance is bell-shaped, with a maximum at about pH 7.4 (Fig. 4) The general appearance of the acid part of the titration resembles that observed for the 470 nm absorbance of ironsaturated transferrin (Lestas, 1976) . In both cases, at pH 5.5, the absorbance is reduced to -25 % of its maximum value, which occurs at about pH 7.5. A major difference between the two, however, is that whereas the absorbance decreases sharply as the pH is reduced below 7.5 for Al-HSTF, for Fe-HSTF the absorbance remained constant until about pH 6.4. This may be related to the fact that the Fe-HSTF study was carried out with solutions lacking HCO3- (Lestas, 1976) . If so, this suggests the pK. of 6.7 detected in the present Al-HSTF study may be the protonation of the bound carbonate. HSTF and citrate. A spectrophotometric titration of 14 ftM-HSTF, at pH 7.4 (0.1 M-Tris/40 mM-NaCI) and 37°C in the presence of 25 mM-NaHCO3, on its own and with the addition of 100 ,uM-citrate, was carried out. Because of the interest in the metal-binding capabilities of HSTF in blood plasma, a similar titration was performed at the physiological concentrations of HSTF (35 /sM) and citrate (100 /LM).
The changes in absorbance at 240 nm (As) for a 2:1
[Al3+t]/[HSTF] solution, against an increasing molar ratio of citrate to HSTF were measured (Fig. 5, line A) . Metal exchange reactions involving HSTF and citrate can be quite slow, so special care was taken to ensure that the results reflected the thermodynamic equilibrium, rather than kinetic factors, by carrying out experiments with citrate added to A1-HSTF, and with A13+ added to a mixture of citrate and HSTF.
These results show, in good agreement with the findings of Cochran et al. (1987) These results are in good agreement with those obtained in previous studies (King et al., 1982; Trapp, 1983; Bertholf et al., 1984; Farrar et al., 1990) Fig. 6 indicates that -60 % of it is bound to HSTF, -340% to HSA and the remainder to citrate. At a concentration of 7.6,M-Al3+, only -500% of it is bound to HSTF.
The above values for A13+ binding can be compared with the speciation calculations described by Harris & Sheldon (1990 (Chasteen, 1977) .
The observation that, even at the relatively high concentrations of citrate used for our experiments with HSTF and HSA, comparatively little A13+ is bound by it, implies that citrate is not a significant Al3+-binding component in plasma. Much of the plasma citrate will be bound to Mg2+, and thus not free to bind to A13+, and so our data overstate considerably the amount of A13+ that will be bound to citrate in plasma.
The effect of pH on the A13+ binding to HSTF is striking (Figs. 
